» Articles » PMID: 30904963

Engineered Microscale Hydrogels for Drug Delivery, Cell Therapy, and Sequencing

Overview
Date 2019 Mar 25
PMID 30904963
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Engineered microscale hydrogels have emerged as promising therapeutic approaches for the treatment of various diseases. These microgels find wide application in the biomedical field because of the ease of injectability, controlled release of therapeutics, flexible means of synthesis, associated tunability, and can be engineered as stimuli-responsive. While bulk hydrogels of several length-scale dimensions have been used for over two decades in drug delivery applications, their use as microscale carriers of drug and cell-based therapies is relatively new. Herein, we critically summarize the fundamentals of hydrogels based on their equilibrium and dynamics of their molecular structure, as well as solute diffusion as it relates to drug delivery. In addition, examples of common microgel synthesis techniques are provided. The ability to tune microscale hydrogels to obtain controlled release of therapeutics is discussed, along with microgel considerations for cell encapsulation as it relates to the development of cell-based therapies. We conclude with an outlook on the use of microgels for cell sequencing, and the convergence of the use of microscale hydrogels for drug delivery, cell therapy, and cell sequencing based systems.

Citing Articles

ROS-scavenging ultrasonicated graphene oxide/alginate microgels for mesenchymal stem cell delivery and hindlimb ischemia treatment.

Lee S, Choe G, Yi J, Kim J, Lee S, Jeon J Mater Today Bio. 2025; 29:101289.

PMID: 40018436 PMC: 11866165. DOI: 10.1016/j.mtbio.2024.101289.


A synthetic chronogenetic gene circuit for programmed circadian drug delivery.

Pferdehirt L, Damato A, Lenz K, Gonzalez-Aponte M, Palmer D, Meng Q Nat Commun. 2025; 16(1):1457.

PMID: 39920119 PMC: 11806060. DOI: 10.1038/s41467-025-56584-5.


The microparticulate inks for bioprinting applications.

An C, Zhang S, Xu J, Zhang Y, Dou Z, Shao F Mater Today Bio. 2024; 24:100930.

PMID: 38293631 PMC: 10825055. DOI: 10.1016/j.mtbio.2023.100930.


Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective.

Puranik N, Yadav D, Song M Int J Mol Sci. 2023; 24(18).

PMID: 37762346 PMC: 10530821. DOI: 10.3390/ijms241814044.


An Innovative Polymeric Platform for Controlled and Localized Drug Delivery.

Elbjorn M, Provencio J, Phillips P, Sainz J, Harrison N, Rocco D Pharmaceutics. 2023; 15(7).

PMID: 37513982 PMC: 10385353. DOI: 10.3390/pharmaceutics15071795.


References
1.
Foster G, Headen D, Gonzalez-Garcia C, Salmeron-Sanchez M, Shirwan H, Garcia A . Protease-degradable microgels for protein delivery for vascularization. Biomaterials. 2016; 113:170-175. PMC: 5121008. DOI: 10.1016/j.biomaterials.2016.10.044. View

2.
Gonzalez-Sanchez M, Rubio-Retama J, Lopez-Cabarcos E, Valero E . Development of an acetaminophen amperometric biosensor based on peroxidase entrapped in polyacrylamide microgels. Biosens Bioelectron. 2010; 26(5):1883-9. DOI: 10.1016/j.bios.2010.03.024. View

3.
Lan F, Demaree B, Ahmed N, Abate A . Single-cell genome sequencing at ultra-high-throughput with microfluidic droplet barcoding. Nat Biotechnol. 2017; 35(7):640-646. PMC: 5531050. DOI: 10.1038/nbt.3880. View

4.
Klein A, Mazutis L, Akartuna I, Tallapragada N, Veres A, Li V . Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell. 2015; 161(5):1187-1201. PMC: 4441768. DOI: 10.1016/j.cell.2015.04.044. View

5.
Park J, Choi S, Kamath R, Yoon Y, Allen M, Prausnitz M . Polymer particle-based micromolding to fabricate novel microstructures. Biomed Microdevices. 2006; 9(2):223-34. DOI: 10.1007/s10544-006-9024-4. View